Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-25 @ 2:43 AM
NCT ID:
NCT03435133
Eligibility Criteria:
Inclusion Criteria:
* age 18 years or older and equal or less than 75 years
* symptom onset within 12 hours before random assignment
* chest pain lasting more than 30 minutes
* ST-segment elevation of at least 0.1 mV in at least 2 limb leads, ST-segment elevation of at least 0.2 mV in 2 or more contiguous precordial leads, or left bundle-branch block or paced rhythm
* time from symptoms onset to randomization less than 6 hours
* no severe heart failure (Killip class \<3)
* informed, written consent
Exclusion Criteria:
* history of myocardial infarction with Q wave
* history of surgical or percutaneous coronary revascularization
* cardiogenic shock, defined as a systolic blood pressure \<90 mm Hg with no response to fluid administration or \<100 mm Hg in patients with supportive treatment and no bradycardia
* history of stroke
* history of bronchial asthma
* symtomatic sinusal bradicardia or advance AV block
* history of hypersensitivity to aspirin, prasugrel or ticagrelor or contraindication to the doses established in the study
* patients pretreated with 600 mg of clopidogrel or more
* contraindication for the use of gadolinium during the magenitc resonance
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03435133
Study Brief:
Protocol Section:
NCT03435133